Cargando…
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial
BACKGROUND: To evaluate the efficacy and safety of 10 mg and 25 mg mifepristone per day compared with 3.75 mg enantone in treating uterine fibroids. METHODS: This is a Multicenter randomized controlled trial. A total of 501 subjects with symptomatic uterine fibroids were enrolled and randomized into...
Autores principales: | Liu, Chongdong, Lu, Qi, Qu, Hong, Geng, Li, Bian, Meilu, Huang, Minli, Wang, Huilan, Zhang, Youzhong, Wen, Zeqing, Zheng, Shurong, Zhang, Zhenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319529/ https://www.ncbi.nlm.nih.gov/pubmed/28207540 http://dx.doi.org/10.1097/MD.0000000000006124 |
Ejemplares similares
-
The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017) -
Hemoperitoneum associated with uterine fibroids: A case report
por: Daimon, Atsushi, et al.
Publicado: (2021) -
The Research of Feasibility and Efficacy of Radiofrequency Ablation in Treating Uterine Fibroids
por: Luo, Xin, et al.
Publicado: (2015) -
Long-term use of ultra-low-dose mifepristone for uterine leiomyoma control and safety discussion: A case report
por: Zhou, Guangdi, et al.
Publicado: (2022) -
Comparison of hysterectomy and uterine artery embolization in the treatment of symptomatic uterine fibroids: A protocol for systematic review and meta-analysis
por: Chen, Ruizhi, et al.
Publicado: (2022)